SCIENTIFIC BACKGROUND

CFTR

Category:

Scientific Background

Cystic fibrosis (CF) is one of the most common autosomal recessive inherited diseases in the Caucasian population (frequency 1:2500, frequency of carriers 1:25). Affected persons suffer from chronic pulmonary symptoms (frequent bronchopulmonary infections, persistent bronchiectasis) and gastrointestinal symptoms (pancreatic insufficiency, pancreatitis, meconium ileus (pre- or neonatal)), and male infertility is seen. It is caused by pathogenic changes in the CFTR (cystic fibrosis transmembrane conductance regulator) gene, which leads to the functional disruption of a chloride channel in the apical membrane of glandular epithelial cells and thus to a change in the salt content of sweat and other body secretions.

 

The most frequently detected pathogenic alteration of the CFTR gene in many populations is the variant p.Phe-508del (F508del). There are >2000 other pathogenic changes in the CFTR gene currently described that are significantly less frequent. The development of the disease depends on the type and severity of the CFTR variants. In addition to the classical, early manifesting and multisystemic cystic fibrosis, milder, monosymptomatic forms have also been described and are grouped under the so-called CFTR-RDs (related disorder). These include disseminated bronchiectasis, atypical chronic rhinosinusitis, chronic pancreatitis or CBAVD (congenital bilateral aplasia of the vas deferens).

 

Early diagnosis is of great importance with regard to optimal care of those affected. Molecular genetic diagnostics to confirm the suspected clinical diagnosis and determine the CFTR genotype can have a decisive influence on the later choice of therapy. CF diagnostics have also been part of newborn screening since 2016.

 

References

Goetz et Ren 2019, Pediatr Ann 48:e154 / Wiencek et Lo 2018, Clin Chem 64:898 / Sosnay et al. 2017, J Pediatr 181S:S52 / Farrell et al. 2017, J Pediatr 181S:S4 / Dequeker et al. 2009, Eur J Hum Genet 17:51 / Castellani et al. 2008, J Cyst Fibros 7:179 / Ogino et al. 2004 J Med Genet 41:e70 / Steiner et al. 2004, Hum Mutat 24:120 / Bobadilla et al. 2002, Hum Mutat 19:575 / Claustres et al. 2000, Hum Mutat 16:143

GENES

CFTR

ASSOCIATED TESTS

How to order

LATEST ARTICLES

A recent study highlights promising outcomes for BRCA variant carriers with breast cancer undergoing breast-conserving therapy. Analyzing 172 women, ...

Read more

Epidermolysis bullosa (EB), sometimes called butterfly skin, is a group of rare skin diseases with a common symptom: fragile skin that tears and blis...

Read more

In the rapidly evolving field of human genetics diagnostics, laboratories face the challenge of keeping up with the latest advancements in technology...

Read more

Medicine as we know it has been around for just over 100 years. Before this, alcohol and opium were the main forms of pain relief in Europe. The deve...

Read more

Below you can read the two winning essays from the second annual DNA essay competition. The subject of the essay was “Family history is one of the ...

Read more

Mosaicism is the presence of two or more genetically different sets of cells within the same person. It is a biological phenomenon that may have no e...

Read more

Cystic fibrosis (CF) is a life-threatening, progressive, inherited condition that causes severe damage to the body, mainly to organs of the respirato...

Read more

Cancer can sometimes run in families; in fact, it is estimated that 5-10% of all cancer cases are inherited. This includes up to 10% of breast cancer...

Read more

Mosaicism is a biological phenomenon in which a person has two or more genetically different sets of cells. Although mosaicism may have no effect, it...

Read more

Background information on in vitro diagnostic services Laboratory-based testing methods and medical devices play a critical role in diagnosis and ...

Read more